Cite
HARVARD Citation
Zhou, Z. et al. (2023). P035 SLC26A9 promotes the development and stemness of triple-negative breast cancer via activating EGFR/PI3 K/AKT signaling pathway. Breast. pp. S29-S30. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhou, Z. et al. (2023). P035 SLC26A9 promotes the development and stemness of triple-negative breast cancer via activating EGFR/PI3 K/AKT signaling pathway. Breast. pp. S29-S30. [Online].